(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ZILEC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ZILEC

ST13

US500000086973504

Class

5

Filing

86973504

Registration

6021346

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

04/01/2025

Trademark type

Combined

Nice classes

5

Filing date

04/12/2016

Registration date

03/31/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/31/2020

Last transaction

04/01/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

03/15/2014

First use in commerce

03/15/2014

Drawing code

5

Owner type

99

Owner location

Hangzhou,Zhejiang, CN

Examiner

COLEMAN,NICHOLAS A

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of word "Zilec" and letter "Z" is in capital letter.

Holders and representatives

Holders

Zhejiang Strong Pharmaceutical Co., Ltd.

Representatives

Jinling Li

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-infective products for veterinary use; Antiallergic medicines; Capsules sold empty for pharmaceuticals; Cardiotonics; Culture fluids for cultivating humananimal cells; Diagnostic preparations for veterinary purposes; Dietary and nutritional supplements; Edible fish oils for medical purposes; Enzymes for veterinary purposes; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Gelatin capsules sold empty for pharmaceuticals; Ginseng capsules for medical purposes; Medicines for intestinal disorders; Medicines for the treatment of gastrointestinal diseases; Mineral food supplements; Mineral nutritional supplements; Mineral preparations for medical purposes; Natural supplements for treating depression and anxiety; Nutritional supplements; Pearl powder for medical purposes; Pharmaceutical preparationsa blood clotting aid and delivery system for use in human and veterinary medicine; Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Royal jelly for medical purposes; Sedatives; Soporifics; Stem cells for veterinary purposes; Sugar for medical purposes; Vitamin fortified beverages for medical purposes; Vitamin and mineral preparations for medical use

Publications

History of USPTO decisions and trademark events.

26 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

03/31/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

03/31/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/14/2020

PUBO

PUBLISHED FOR OPPOSITION

01/14/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/25/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/06/2019

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

09/25/2019

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

03/25/2019

DOCK

ASSIGNED TO EXAMINER

03/06/2019

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

09/17/2018

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

03/15/2018

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

09/12/2017

ALIE

ASSIGNED TO LIE

09/12/2017

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/27/2017

GNSL

LETTER OF SUSPENSION E-MAILED

02/27/2017

CNSL

SUSPENSION LETTER WRITTEN

02/27/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/09/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/08/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/08/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/08/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/08/2016

GNRT

NON-FINAL ACTION E-MAILED

08/08/2016

CNRT

NON-FINAL ACTION WRITTEN

08/08/2016

DOCK

ASSIGNED TO EXAMINER

07/26/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/16/2016

NWAP

NEW APPLICATION ENTERED

04/15/2016

Continuous trademark protection

Get notified about every new filing that threatens ZILEC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.